Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
申请人:Archer Ann Janet
公开号:US20060122234A1
公开(公告)日:2006-06-08
A compound of formula (I): which can be used in the treatment of diseases associated with histone deacetylase enzymatic activity.
一种式(I)化合物:可用于治疗与组蛋白去乙酰化酶酶活性有关的疾病。
SUBSTITUTED THIENYL-HYDROXAMIC ACIDS AS HISTONE DEACETYLASE INHIBITORS
申请人:Argenta Discovery Limited
公开号:EP1525199A1
公开(公告)日:2005-04-27
[EN] SUBSTITUTED THIENYL-HYDROXAMIC ACIDS AS HISTONE DEACETYLASE INHIBITORS<br/>[FR] ACIDES SUBSTITUES THIENYLHYDROXAMIQUES UTILISES EN TANT QU'INHIBITEURS D'HISTONE DESACETYLASE
申请人:ARGENTA DISCOVERY LTD
公开号:WO2004013130A1
公开(公告)日:2004-02-12
A compound of formula (I): which can be used in the treatment of diseases associated with histone deacetylase enzymatic activity.
化合物的化学式(I):可用于治疗与组蛋白去乙酰化酶活性相关的疾病。
Structure–Activity Relationship of Anti-<i>Mycobacterium abscessus</i> Piperidine-4-carboxamides, a New Class of NBTI DNA Gyrase Inhibitors
作者:Andreas Beuchel、Dina Robaa、Dereje A. Negatu、Abdeldjalil Madani、Nadine Alvarez、Matthew D. Zimmerman、Adrian Richter、Lea Mann、Sophie Hoenke、René Csuk、Thomas Dick、Peter Imming
DOI:10.1021/acsmedchemlett.1c00549
日期:2022.3.10
evidence suggesting that P4Cs display a similar binding mode to DNAgyrase as gepotidacin. Gepotidacin is a member of the NovelBacterialTopoisomeraseInhibitors (NBTIs), a new class of nonfluoroquinolone DNAgyrase poisons. Thus, our work suggests that P4Cs present a novelstructural subclass of NBTI. We describe structure–activity relationship studies of 844 leading to analogues showing increased
脓肿分枝杆菌会导致难以治愈的肺部感染。该细菌对大多数抗感染药物具有耐药性,包括一线抗结核(抗结核)药物。MMV688844 ( 844 ) 是一种哌啶-4-甲酰胺 (P4C),对脓肿分枝杆菌具有杀菌特性。我们最近将 DNA 促旋酶鉴定为844的分子靶标。在这里,我们展示了计算机对接和遗传证据表明 P4C 与 DNA 促旋酶显示出与 gepotidacin 相似的结合模式。Gepotidacin 是新型细菌拓扑异构酶抑制剂 (NBTI) 的成员,NBTI 是一类新的非氟喹诺酮类 DNA 促旋酶毒物。因此,我们的工作表明 P4Cs 是 NBTI 的一个新的结构子类。我们描述了844的结构-活性关系研究,导致类似物显示出增强的抗菌活性。测试了所选衍生物对重组脓肿分枝杆菌DNA 促旋酶的抑制活性。先导结构的进一步优化提高了小鼠血浆中的稳定性并提高了口服生物利用度。